Case Report: Fatal presumptive idiosyncratic hepatic necrosis secondary to standard-dose leflunomide administration in a dog

An 8-year-old neutered male Greyhound was presented with intermittent lameness and joint pain, leading to a diagnosis of idiopathic immune-mediated polyarthritis. The initial treatment regimen involved prednisone and minocycline. Leflunomide (3 mg/kg PO q24h) was prescribed later for secondary immun...

Full description

Saved in:
Bibliographic Details
Main Authors: Cristina Aponte-Colon, Lauren A. Cochran, Lauren Harris, Erick A. Mears, Steven W. Frederick
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2025.1529324/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850036255864127488
author Cristina Aponte-Colon
Lauren A. Cochran
Lauren Harris
Erick A. Mears
Steven W. Frederick
author_facet Cristina Aponte-Colon
Lauren A. Cochran
Lauren Harris
Erick A. Mears
Steven W. Frederick
author_sort Cristina Aponte-Colon
collection DOAJ
description An 8-year-old neutered male Greyhound was presented with intermittent lameness and joint pain, leading to a diagnosis of idiopathic immune-mediated polyarthritis. The initial treatment regimen involved prednisone and minocycline. Leflunomide (3 mg/kg PO q24h) was prescribed later for secondary immune modulation. Five weeks later, the dog exhibited signs of acute lethargy, weakness, and increased liver enzyme activities (alanine aminotransferase [ALT] 6,613 U/L and aspartate aminotransferase [AST] 3,718 U/L). Despitereceiving supportive care, the dog died. Necropsy revealed massive hepatic necrosis with effaced hepatic architecture and centrilobular pools of free blood, similar to findings noted in people with leflunomide-induced hepatic injury. This case highlights a previously unreported severe, idiosyncratic hepatotoxicity associated with standard doses of leflunomide in dogs, illustrating the need for vigilant monitoring and increased awareness of the potential need for dose adjustment if liver enzyme elevations occur.
format Article
id doaj-art-d2377eb36fb747feaa57389ab1d9bbb5
institution DOAJ
issn 2297-1769
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj-art-d2377eb36fb747feaa57389ab1d9bbb52025-08-20T02:57:13ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692025-05-011210.3389/fvets.2025.15293241529324Case Report: Fatal presumptive idiosyncratic hepatic necrosis secondary to standard-dose leflunomide administration in a dogCristina Aponte-Colon0Lauren A. Cochran1Lauren Harris2Erick A. Mears3Steven W. Frederick4Blue Pearl Veterinary Partners, Tampa, FL, United StatesBlue Pearl Veterinary Partners, Tampa, FL, United StatesBlue Pearl Veterinary Partners, Tampa, FL, United StatesBlue Pearl Veterinary Partners, Tampa, FL, United StatesBlue Pearl Veterinary Science, Atlanta, GA, United StatesAn 8-year-old neutered male Greyhound was presented with intermittent lameness and joint pain, leading to a diagnosis of idiopathic immune-mediated polyarthritis. The initial treatment regimen involved prednisone and minocycline. Leflunomide (3 mg/kg PO q24h) was prescribed later for secondary immune modulation. Five weeks later, the dog exhibited signs of acute lethargy, weakness, and increased liver enzyme activities (alanine aminotransferase [ALT] 6,613 U/L and aspartate aminotransferase [AST] 3,718 U/L). Despitereceiving supportive care, the dog died. Necropsy revealed massive hepatic necrosis with effaced hepatic architecture and centrilobular pools of free blood, similar to findings noted in people with leflunomide-induced hepatic injury. This case highlights a previously unreported severe, idiosyncratic hepatotoxicity associated with standard doses of leflunomide in dogs, illustrating the need for vigilant monitoring and increased awareness of the potential need for dose adjustment if liver enzyme elevations occur.https://www.frontiersin.org/articles/10.3389/fvets.2025.1529324/fullcase reportimmune-mediatedpolyarthritisIMPAliver enzyme
spellingShingle Cristina Aponte-Colon
Lauren A. Cochran
Lauren Harris
Erick A. Mears
Steven W. Frederick
Case Report: Fatal presumptive idiosyncratic hepatic necrosis secondary to standard-dose leflunomide administration in a dog
Frontiers in Veterinary Science
case report
immune-mediated
polyarthritis
IMPA
liver enzyme
title Case Report: Fatal presumptive idiosyncratic hepatic necrosis secondary to standard-dose leflunomide administration in a dog
title_full Case Report: Fatal presumptive idiosyncratic hepatic necrosis secondary to standard-dose leflunomide administration in a dog
title_fullStr Case Report: Fatal presumptive idiosyncratic hepatic necrosis secondary to standard-dose leflunomide administration in a dog
title_full_unstemmed Case Report: Fatal presumptive idiosyncratic hepatic necrosis secondary to standard-dose leflunomide administration in a dog
title_short Case Report: Fatal presumptive idiosyncratic hepatic necrosis secondary to standard-dose leflunomide administration in a dog
title_sort case report fatal presumptive idiosyncratic hepatic necrosis secondary to standard dose leflunomide administration in a dog
topic case report
immune-mediated
polyarthritis
IMPA
liver enzyme
url https://www.frontiersin.org/articles/10.3389/fvets.2025.1529324/full
work_keys_str_mv AT cristinaapontecolon casereportfatalpresumptiveidiosyncratichepaticnecrosissecondarytostandarddoseleflunomideadministrationinadog
AT laurenacochran casereportfatalpresumptiveidiosyncratichepaticnecrosissecondarytostandarddoseleflunomideadministrationinadog
AT laurenharris casereportfatalpresumptiveidiosyncratichepaticnecrosissecondarytostandarddoseleflunomideadministrationinadog
AT erickamears casereportfatalpresumptiveidiosyncratichepaticnecrosissecondarytostandarddoseleflunomideadministrationinadog
AT stevenwfrederick casereportfatalpresumptiveidiosyncratichepaticnecrosissecondarytostandarddoseleflunomideadministrationinadog